Free Trial
NASDAQ:AZTA

Azenta (AZTA) Stock Price, News & Analysis

$60.22
+1.10 (+1.86%)
(As of 07/26/2024 ET)
Today's Range
$59.70
$61.53
50-Day Range
$50.27
$60.22
52-Week Range
$44.00
$69.16
Volume
292,194 shs
Average Volume
464,055 shs
Market Capitalization
$3.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$67.00

Azenta MarketRank™ Stock Analysis

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
11.3% Upside
$67.00 Price Target
Short Interest
Bearish
8.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.17mentions of Azenta in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
57.14%
From $0.28 to $0.44 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.59 out of 5 stars

Medical Sector

714th out of 936 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

10th out of 12 stocks

AZTA stock logo

About Azenta Stock (NASDAQ:AZTA)

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

AZTA Stock Price History

AZTA Stock News Headlines

Concentra Group Holdings Parent Inc.
Nvidia’s Quiet $1 Trillion Pivot
Nvidia recently added $277 billion in market cap … IN ONE DAY.
Nvidia’s Quiet $1 Trillion Pivot
Nvidia recently added $277 billion in market cap … IN ONE DAY.
The Analyst Landscape: 7 Takes On Azenta
Azenta Announces CEO Succession Plan
See More Headlines
Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/06/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Special industry machinery, not elsewhere classified
Sub-Industry
Machinery
Current Symbol
NASDAQ:AZTA
Employees
3,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$67.00
High Stock Price Target
$79.00
Low Stock Price Target
$53.00
Potential Upside/Downside
+11.3%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-14,260,000.00
Pretax Margin
-24.91%

Debt

Sales & Book Value

Annual Sales
$665.07 million
Cash Flow
$1.73 per share
Book Value
$42.10 per share

Miscellaneous

Free Float
52,946,000
Market Cap
$3.25 billion
Optionable
Optionable
Beta
1.51
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Dr. Stephen S. Schwartz (Age 65)
    CEO, President & Director
    Comp: $1.05M
  • Mr. Robin Vacha (Age 48)
    Senior Vice President of Global Operations
    Comp: $533.35k
  • Mr. Jason W. Joseph (Age 53)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $544.13k
  • Mr. Herman Cueto (Age 50)
    Executive VP & CFO
  • Ms. Violetta Hughes (Age 52)
    VP & Chief Accounting Officer
  • Mr. Michael Paulo
    VP and Chief Information & Digital Officer
  • Mr. John E. O'Brien (Age 54)
    Senior Vice President of Corporate Development
  • Ms. Olga Pirogova (Age 50)
    Senior VP & Chief HR Officer
  • Mr. J. Robert Woodward
    Senior Vice President of Global Quality & Regulatory
  • Dr. Ginger Zhou Ph.D. (Age 47)
    Senior VP & GM of Multiomics and Synthesis Solutions

AZTA Stock Analysis - Frequently Asked Questions

How have AZTA shares performed this year?

Azenta's stock was trading at $65.14 at the beginning of 2024. Since then, AZTA stock has decreased by 7.6% and is now trading at $60.22.
View the best growth stocks for 2024 here
.

How were Azenta's earnings last quarter?

Azenta, Inc. (NASDAQ:AZTA) issued its quarterly earnings results on Wednesday, May, 8th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.03. The business's revenue was up 7.2% on a year-over-year basis.

Who are Azenta's major shareholders?

Top institutional shareholders of Azenta include Allspring Global Investments Holdings LLC (2.07%), Bank of New York Mellon Corp (0.96%), Raymond James & Associates (0.21%) and Retirement Systems of Alabama (0.12%). Insiders that own company stock include David C Gray, Matthew Mcmanus, Kimberly Crowley and Jesus Linda De.
View institutional ownership trends
.

How do I buy shares of Azenta?

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AZTA) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners